The energy tail risk no oneβs talking about, why a retail giant got double-downgraded, a candidate for the next IPO pop, and more.
Nov 15, 2025
Oct 3, 2026
β’
1 min read
Plus, a vaccine maker weeks from its pivotal test....
Oct 1, 2026
One stock pick from a top-ranked analyst with an implied upside of 100% or more.
Sep 26, 2026
Plus, a precision medicine company betting on human genetics....